Dr. Bennett is featured or cited in the following articles:
Mind the ketamine education gap: Serious adverse events in clinical ketamine treatment
MedPage Today
By Raquel Bennett, Psy.D. and Christian Yavorsky, Ph.D.
March 19, 2021
Group ketamine-assisted psychotherapy: Practice and promises of a new frontier
Psychedelics Today
By Sean Lawlor
March 10, 2021
Elijah McClain’s death spotlights ketamine use in law enforcement actions
Lucid News
By Nicholas Powers and Ann Harrison
August 6, 2020
Safety of repeated administration of parenteral ketamine for depression
Pharmaceuticals
By David Feifel, M.D. and David Dadiomov, Pharm.D. and Kelly Lee, Pharm.D.
July 13, 2020
Proposed patent for ketamine treatment challenged by clinicians
Lucid News
By Ali McGhee and Ann Harrison
July 1, 2020
Promise, power, and profit: The economics of ketamine treatment
MAPS Bulletin
By Raquel Bennett, Psy.D. and Alexander Belser, Ph.D.
Spring 2020
Ketamine for depression and mood disorders
Townsend Letter
By Erica Zelfand, N.D.
January 2020
Visions to heed: Ketamine’s breakout in psychedelic therapy
Psychedelic Support
By Dan Bernitt
May 1, 2019
Paradigms of ketamine treatment – FEATURED
MAPS Bulletin
By Raquel Bennett, Psy.D.
Spring 2019
Listening to ketamine
Knowable Magazine
By Emily Underwood
March 29, 2019
Psychedelic feminism: A radical interpretation of psychedelic consciousness?
Journal for the Study of Radicalism
By Kim Hewitt, Ph.D.
January 2019
Cited on pp. 97-99
Ketamine KRIYA Conference 2018: The most phenomenal ketamine conference to date!
Blog Post
By Lori Calabrese, M.D.
November 21, 2018
Rapid depression remission and the “therapeutic bends” with ketamine-assisted psychotherapy
Psychedelics Today
By Jessica Katzman, Psy.D.
September 8, 2018
Ketamine stirs up hope – and controversy – as a depression drug
WIRED
By Moises Velasquez-Manoff
May 2018
Opportunities and strategies for a ketamine psychotherapeutics (KAP)
The Ketamine Papers
By Phil Wolfson, M.D.
November 2016
Cited on pp. 339-340